Bi-weekly intravenous cyclophosphamide as remission induction therapy for pediatric vasculitis.

被引：0
|
作者：
Bracaglia, Claudia
Cortis, Elisabetta
Zurakowski, David
Sundel, Robert P.
机构：
[1] Osped Bambino Gesu, Rome, Italy
[2] Childrens Hosp, Boston, MA 02115 USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4060 / 4060
页数：1
相关论文
共 50 条
  • [31] Induction of Remission with Intravenous Immunoglobulin and Cyclophosphamide in Steroid-Resistant Evans’ Syndrome Associated with Dermatomyositis
    Dae-Kook Chang
    Dae-Hyun Yoo
    Tae-Hwan Kim
    Jae-Bum Jun
    In-Hong Lee
    Sang-Cheol Bae
    In Soon Kim
    Seong Yoon Kim
    Clinical Rheumatology, 2001, 20 : 63 - 66
  • [32] Intravenous cyclophosphamide (IVCTX) therapy in pediatric lupus membranous nephropathy.
    Massengill, SF
    Tolaymat, A
    Sleasman, JW
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 973 - 973
  • [33] Fludarabine, Cyclophosphamide, Doxorubicin (FCD), and Rituximab: A Remission Induction Therapy for Aggressive Pediatric Post-Transplant Lymphoproliferative Disease (PTLD)
    Giraldi, Eugenia
    Provenzi, Massimo
    Fiocchi, Roberto
    Colledan, Michele
    Cornelli, Pieremilio
    Torre, Giuliano
    Rambaldi, Alessandro
    Conter, Valentino
    PEDIATRIC BLOOD & CANCER, 2011, 57 (02) : 324 - 328
  • [34] Once Weekly Subcutaneous Bortezomib, Cyclophosphamide, and Dexamethasone As Induction Therapy for All AL Amyloidosis
    Abbas, Hashim
    Rybicki, Lisa A.
    Reu, Frederic J.
    Samaras, Christy
    Smith, Mitchell R.
    Hastings, Debbie
    Valent, Jason
    BLOOD, 2016, 128 (22)
  • [35] Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial
    Harper, Lorraine
    De Groot, Kirsten
    Jayne, David
    Flores Suarez, Luis Felipe
    Gregorini, Gina
    Gross, Wolfgang
    Luqmani, Rashid
    Pusey, Charles
    Rasmussen, Niels
    Sinico, Renato
    Tesar, Vladimir
    Vanhille, Philippe
    Westman, Kerstin
    Savage, Caroline
    APMIS, 2009, 117 : 77 - 77
  • [36] Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis
    Miloslavsky, E.
    Specks, U.
    Merkel, P.
    Seo, P.
    Spiera, R.
    Langford, C.
    Hoffman, G.
    Kallenberg, C.
    St Clair, W.
    Tchao, N.
    Ding, L.
    Ikle, D.
    Jepson, B.
    Brunetta, P.
    Stone, J.
    PRESSE MEDICALE, 2013, 42 (04): : 779 - 780
  • [37] A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer
    Rino, Y
    Takanashi, Y
    Yukawa, N
    Saeki, H
    Wada, H
    Kanari, M
    Yamada, R
    Satoh, T
    Yamamoto, N
    Imada, T
    ANTICANCER RESEARCH, 2006, 26 (2B) : 1455 - 1462
  • [38] Complete remission with long-term survival in a patient with esophageal carcinoma and a tracheoesophageal fistula after treatment with the AIO regimen and bi-weekly cisplatin
    Krauss, N
    Wein, A
    Boxberger, F
    Baum, U
    Männlein, G
    Sezer, O
    Hahn, EG
    Benninger, J
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2004, 42 (08): : 739 - 742
  • [39] Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)
    Shoichiro Ohtani
    Takahiro Nakayama
    Tetsuhiro Yoshinami
    Ken-ichi Watanabe
    Fumikata Hara
    Yasuaki Sagara
    Hidetoshi Kawaguchi
    Kenji Higaki
    Nobuki Matsunami
    Yoshie Hasegawa
    Masato Takahashi
    Makiko Mizutani
    Takashi Morimoto
    Masako Sato
    Mitsuya Itoh
    Satoshi Morita
    Norikazu Masuda
    Breast Cancer, 2018, 25 : 438 - 446
  • [40] A phase I-II study of bi-weekly docetaxel combined with radiation therapy for patients with cancer of the larynx/hypopharynx
    Yoshida, Tomoyuki
    Tokashiki, Ryoji
    Itoh, Hiroyuki
    Nakamura, Kazuhiro
    Hiramatsu, Hiroyuki
    Tsukahara, Kiyoaki
    Shimizu, Shigetaka
    Takada, Daisuke
    Okamoto, Isaku
    Abe, Kimihiko
    Suzuki, Mamoru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (09) : 641 - 646
12345